As one of the world’s largest pharmaceutical company, Pfizer further increased its profile when it became the first to develop and distribute a Covid-19 vaccine.
Always a gainful company manufacturing medicines and vaccines driving the company to earn more than $50 billion annually, Pfizer is proven a profitable company with an essential reputation in the industry that secures its continued longevity.
Do you want to invest on Pfizer? we'll tell you how.
Industry: Drug Manufacturers
On top of a consistent string of profitable performance on the market, Pfizer is expected to earn at least $19 billion from the sales of its Covid-19 vaccine.
Apart from playing a crucial role in finally stopping the Covid-19 pandemic, Pfizer is primed for an even brighter future.
And there’s more…
Pfizer is also considered as having the largest Research and Development finding in the pharmaceutical industry, therefore attracting solid investor and consumer trust.
Bear in mind….
In this article, we will pitch the idea of investing on Pfizer stocks by pondering over its stock performance history and analyst forecast of future share value.
If you’re ready, then let’s start learning about this good investment idea we have: investing on Pfizer stock.
Table of Contents
- Why Buy Pfizer Stock?
- Pfizer Stock Performance
- Pfizer Stock Forecast
- How to Buy Pfizer Stock?
- Frequently Asked Questions (FAQ)
- Best Brokers for Buying Pfizer Stocks
Why Buy Pfizer Stock?
Pfizer not only occupies a great position on the market today due to many positive developments—one of which is their COVID-19 vaccine—Pfizer is also a dividend machine.
Rewarding investors with 4.2% dividend yield, a three-fold increase over the average S&P 500 Companies.
Amassing modest yields during the last ten years, Pfizer still manages to give back to its investors a handsome share of quarterly dividends. This is another huge reason to invest on Pfizer shares.
- Copy investment portfolios of top Pfizer traders
- Buy stocks commission-free
- Practice with a free demo account
- No overnight fees
- Risk management tools
Taking the online trading industry by storm, eToro has now garnered more than 13 million users since it was founded in 2006.
This highly-trusted e-trading application is the ideal investing tool for both seasoned and beginner traders.
Want to know how to use eToro? We will tell you how
- Sign up for an account by creating one at the sign-in page.
- Verify your personal information for security purposes.
- Make your first deposit.
- And as easy as 1,2,3, you can now start trading.
eToro’s fantastic set of features include:
CopyTrading - this is a robust feature that provides users a medium to search and copy successful traders for them to learn and invest properly.
CopyPortfolios - this is another valuable feature that teaches traders the proper way of expanding their portfolios without risking their investments by reducing the chances of experiencing losses through wise trading decisions.
And another thing:
The Analyst Coverage page is where users can find beneficial information about the industry, the market, company stocks, forecasts and other data you can use when making investment decisions.
eToro is also licensed by different regulatory bodies including the following:
- CySEC – Cyprus Securities and Exchange Commission
- FCA – Financial Conduct Authority
- ASIC – Australian Securities and Investments Commission
- Competitive spreads for Pfizer
- Trading with as little as $100
- Fast and reliable order execution
- Risk management tools
- Fully regulated by the FCA, CySEC and ASIC
The trademarked online trading platform of Plus500 is one of the most popular and highly-trusted tools used by investors for investing, trading and managing portfolios.
Trading made easier by Plus500
Plus500’s Integrated Risk Management Tools help users avoid investment risks by giving traders integrated control of their investment.
One more thing…
Plus500 online trading platform follows all rules and guidelines set by financial governing bodies and is regulated by leading regulatory boards:
- Plus500CY Ltd authorized & regulated by CySEC (#250/14).
- Plus500UK Ltd authorised & regulated by the FCA (#509909).
- Plus500SG Pte Ltd, licensed by the MAS (#CMS100648-1) and IE Singapore (#PLUS/CBL/2018).
- Plus500AU Pty Ltd (ACN 153301681), licensed by:
ASIC in Australia, AFSL #417727, FMA in New Zealand, FSP #486026; Authorised Financial Services Provider in South Africa, FSP #47546. You do not own or have any rights to the underlying assets. Please refer to the Disclosure documents available on the website.
Pfizer Stock Performance
With a market cap of $215 billion and a long line of "blockbuster" products out on the market, Pfizer boasts of an almost a century and a half of strong performance and profitability.
Factor in the COVID-19 vaccine and you get one of the most stable and solid stocks in the market today. Just counting on these investing barometers of huge growth projections, robust financial asset, company stability and high dividend, Pfizer is a stock worth investing to and holding on for the long run.
Pfizer Stock Forecast
Below is a summary of Pfizer’s future and its relation to the potential value of its stocks.
These stock forecasts are based on current stock and company performance and is meant to guide your decision-making.
Remember, that the final decision is still yours to make.
2021: Paving the Path to $300 + Billion Market Cap
With a current market cap of more than $215 billion, Pfizer is setting its goals on reaching the milestone figure of $300 billion by 2025. After generating momentum during the era of Covid-19 vaccine it developed in 2020, by 2021, Pfizer is looking to expand and experience solid growth by banking on the potential of its R&D division to produce more revolutionary medicines and vaccines. In the uncertain global economy, it is hard to be fully optimistic about a company, but Pfizer's consistent strong performance and sound management decisions are quickly easing all the doubts.
Our outlook for Pfizer stock remains consistently high so we expect its share value to return high-yield range from low to medium.
2022: Speeding up the Development of Medicine
As part of their plan to speed up development of breakthrough medicines, Pfizer is gearing up to "apply digital advances and quantitative methods to improve" the chances of achieving a successful drug development process. “By adopting new ways to recruit patients, automating processes, integrating systems, and using the totality of data to optimize our protocols, by 2021, we expect to reduce the average time it takes to develop a new medicine by about two years,” says Rod MacKenzie, Chief Development Officer, Pfizer.
Our bullish outlook for this company remains the same. Therefore, the chances of being rewarded for investing on Pfizer stock ranges from medium to high.
How to Buy Pfizer Stock?
Simply follow the steps below and you're good to go:
Open an account with an online broker.
For you to buy Pfizer stock and other company shares, first you need to open an account with a brokerage which offers a platform for trading.
Signing-up for an account only takes a few minutes to accomplish and after completing this process, you need to make a deposit so you can start investing.
Open your broker's trading platform.
Let's say you have opened an account with a specific brokerage and you have already funded it. The next step to do is to open their platform to start trading.
Look for the Pfizer stock (symbol: PFE).
After opening the platform, search for the Pfizer stock by using the search bar and entering either "Pfizer" or its stock symbol "PFE".
Select Buy and set the amount.
Click on "Buy" and specify the amount that you wish to invest. You may also set several specific parameters depending the features that are offered to you by your broker.
Execute the order.
Initiate the trade by executing the order.
Should I buy Pfizer stock?
It is a wise decision to buy into Pfizer stock right now. Most investors would think that the main reason to hop on the Pfizer wagon now is because of the Covid-19 vaccine it developed and is currently rolling out successfully. While that is also correct, another big reason why you should invest on Pfizer stocks is its impressive revenue flow. Analysts see Pfizer's stock as not merely a growth play but also a "cash-flow vehicle".
So, are you are ready to trade Pfizer shares?
If you are now sold on buying and trading Pfizer stocks, then we highly encourage you to look for a highly trusted and regulated brokerage firm that can promise you appropriate management and control of your investments, and also provide you with a peace of mind.
Frequently Asked Questions (FAQ)
How Much is the Pfizer Stock?
Here is the current stock market price of ( )
Who Owns the Most Shares of Pfizer?
The Vanguard Group owns the most number of Pfizer shares with 451,075,687 stocks valued at $ 16,554,477,712.
How Many Outstanding Shares Does Pfizer Have?
Based on latest figures, Pfizer’s outstanding shares is 5.56 billion
Where Can I Buy Pfizer Stock?
When buying Pfizer stocks, we highly recommend the two leading online trading platforms used by many traders today. These are the Plus500 and eToro, two popular CFD (contracts for difference) trading applications trusted by investors all over the world.
Best Brokers for Buying Pfizer Stocks
We've prepared a table of the most trusted and regulated brokers that offers Pfizer stock CFD trading services.
All you have to do is click on the Pfizer Page button of your preferred broker and you will be taken straight to their stock trading page.
Min Deposit: $200
Regulation: CYSEC, FCA
Min Deposit: $100
Regulation: FCA, ASIC, CySEC
Min Deposit: $100
Regulation: CBI, ASIC, FSC, FSA, FSB
Min Deposit: $5
Regulation: IFSC, ASIC, CySEC